{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:20:20Z","timestamp":1789773620552,"version":"4.0.1"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["1144825N"],"award-info":[{"award-number":["1144825N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019771","name":"KU Leuven Rega Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.blre.2025.101285","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T12:22:16Z","timestamp":1742559736000},"page":"101285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Neutrophils in BCR::ABL1 negative MPN: Contributors or bystanders of fibrosis?"],"prefix":"10.1016","volume":"72","author":[{"given":"Ga\u00ebl","family":"Vermeersch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieke","family":"Gouwy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Proost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Struyf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Devos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2025.101285_bb0005","doi-asserted-by":"crossref","unstructured":"Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-2405. Blood 2016;128:462\u20133. doi:https:\/\/doi.org\/10.1182\/blood-2016-06-721662.","DOI":"10.1182\/blood-2016-06-721662"},{"key":"10.1016\/j.blre.2025.101285_bb0010","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ajh.26857","article-title":"Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2025.101285_bb0015","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1016\/S2352-3026(23)00305-8","article-title":"Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT\/ELN International Working Group","volume":"11","author":"Kr\u00f6ger","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.blre.2025.101285_bb0020","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1038\/bcj.2017.6","article-title":"The role of the extracellular matrix in primary myelofibrosis","volume":"7","author":"Leiva","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.blre.2025.101285_bb0025","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0030","doi-asserted-by":"crossref","first-page":"20262","DOI":"10.1073\/pnas.0706438104","article-title":"Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis","volume":"104","author":"Ardi","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.blre.2025.101285_bb0035","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fimmu.2014.00508","article-title":"Neutrophil-derived cytokines: facts beyond expression","volume":"5","author":"Tecchio","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2025.101285_bb0040","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3390\/ijms23031490","article-title":"Neutrophil death in myeloproliferative neoplasms: shedding more light on neutrophils as a pathogenic link to chronic inflammation","volume":"23","author":"Markovi\u0107","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.blre.2025.101285_bb0045","doi-asserted-by":"crossref","first-page":"9555","DOI":"10.3390\/ijms22179555","article-title":"The role of neutrophilic granulocytes in Philadelphia chromosome negative myeloproliferative neoplasms","volume":"22","author":"Kiem","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.blre.2025.101285_bb0050","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.3324\/haematol.2019.230193","article-title":"Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression","volume":"105","author":"Geyer","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2025.101285_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-024-00994-z","article-title":"Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms\u2014a Danish longitudinal study","volume":"14","author":"Larsen","year":"2024","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.blre.2025.101285_bb0060","first-page":"1448","article-title":"Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications","volume":"28","author":"Boiocchi","year":"2015","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.blre.2025.101285_bb0065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2308511120","article-title":"The total mass, number, and distribution of immune cells in the human body","volume":"120","author":"Sender","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.blre.2025.101285_bb0070","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.V80.8.2012.2012","article-title":"Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products","volume":"80","author":"Colotta","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0075","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2019.04.013","article-title":"The neutrophil life cycle","volume":"40","author":"Hidalgo","year":"2019","journal-title":"Trends Immunol"},{"key":"10.1016\/j.blre.2025.101285_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/imr.13177","article-title":"Current knowledge on the early stages of human neutropoiesis","volume":"314","author":"Calzetti","year":"2023","journal-title":"Immunol Rev"},{"key":"10.1016\/j.blre.2025.101285_bb0085","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood.2021012835","article-title":"The journey of neutropoiesis: how complex landscapes in bone marrow guide continuous neutrophil lineage determination","volume":"139","author":"Overbeeke","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1172\/JCI115860","article-title":"Stimulus-dependent secretion of plasma proteins from human neutrophils","volume":"90","author":"Borregaard","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2025.101285_bb0095","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.it.2007.06.002","article-title":"Neutrophil granules: a library of innate immunity proteins","volume":"28","author":"Borregaard","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.blre.2025.101285_bb0100","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1189\/jlb.1212619","article-title":"Proteome profiling of human neutrophil granule subsets, secretory vesicles, and cell membrane: correlation with transcriptome profiling of neutrophil precursors","volume":"94","author":"R\u00f8rvig","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.blre.2025.101285_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00057-17","article-title":"The ontogeny of a neutrophil: mechanisms of granulopoiesis and homeostasis","volume":"82","author":"Lawrence","year":"2018","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.blre.2025.101285_bb0110","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/med.21958","article-title":"Fast and furious: the neutrophil and its armamentarium in health and disease","volume":"43","author":"Metzemaekers","year":"2023","journal-title":"Med Res Rev"},{"key":"10.1016\/j.blre.2025.101285_bb0115","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3390\/cells9092136","article-title":"Cytokine profiling in myeloproliferative neoplasms: overview on phenotype correlation, outcome prediction, and role of genetic variants","volume":"9","author":"Masselli","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.blre.2025.101285_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000031","article-title":"Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes","volume":"1","author":"Nagaev","year":"2006","journal-title":"PLoS ONE"},{"key":"10.1016\/j.blre.2025.101285_bb0125","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood-2016-09-670224","article-title":"Myeloid malignancies and the microenvironment","volume":"129","author":"Korn","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0130","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1182\/blood-2014-09-570192","article-title":"Making sense of hematopoietic stem cell niches","volume":"125","author":"Boulais","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0135","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12967-023-04393-z","article-title":"Fibrosis and bone marrow: understanding causation and pathobiology","volume":"21","author":"Ghosh","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.blre.2025.101285_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","article-title":"TGF\u03b2 biology in cancer progression and immunotherapy","volume":"18","author":"Derynck","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.blre.2025.101285_bb0145","doi-asserted-by":"crossref","first-page":"17058","DOI":"10.1074\/jbc.M100754200","article-title":"Identification of novel TGF-beta \/Smad gene targets in dermal fibroblasts using a combined cDNA microarray\/promoter transactivation approach","volume":"276","author":"Verrecchia","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2025.101285_bb0150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.redox.2015.09.009","article-title":"Reciprocal regulation of TGF-\u03b2 and reactive oxygen species: a perverse cycle for fibrosis","volume":"6","author":"Liu","year":"2015","journal-title":"Redox Biol"},{"key":"10.1016\/j.blre.2025.101285_bb0155","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00109-021-02083-1","article-title":"Expression and function of Smad7 in autoimmune and inflammatory diseases","volume":"99","author":"Hu","year":"2021","journal-title":"J Mol Med Berl Ger"},{"key":"10.1016\/j.blre.2025.101285_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216810","article-title":"Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures","volume":"14","author":"Wong","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.blre.2025.101285_bb0165","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/s41375-019-0379-y","article-title":"Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NF\u03baB signaling","volume":"33","author":"Fisher","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2025.101285_bb0170","first-page":"15","article-title":"Elevated levels of damage-associated molecular patterns HMGB1 and S100A8\/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis","author":"De Luca","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2025.101285_bb0175","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.stem.2020.11.004","article-title":"Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis","volume":"28","author":"Leimk\u00fchler","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.blre.2025.101285_bb0180","first-page":"1977","article-title":"A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial","volume":"109","author":"Verstovsek","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2025.101285_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000111","article-title":"Serum amyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo","volume":"1","author":"Casta\u00f1o","year":"2009","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.blre.2025.101285_bb0190","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.matbio.2020.04.006","article-title":"Extracellular matrix-derived peptides in tissue remodeling and fibrosis","volume":"91\u201392","author":"de Castro Br\u00e1s","year":"2020","journal-title":"Matrix Biol"},{"key":"10.1016\/j.blre.2025.101285_bb0195","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.4049\/jimmunol.180.8.5662","article-title":"A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic Inflammation12","volume":"180","author":"Gaggar","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.blre.2025.101285_bb0200","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1182\/blood-2016-02-699959","article-title":"Importance of environmental stiffness for megakaryocyte differentiation and proplatelet formation","volume":"128","author":"Aguilar","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0205","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/blood-2014-08-595561","article-title":"Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies","volume":"125","author":"Di Buduo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0210","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ajh.27184","article-title":"Newly identified roles for PIEZO1 mechanosensor in controlling normal megakaryocyte development and in primary myelofibrosis","volume":"99","author":"Abbonante","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2025.101285_bb0215","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13045-018-0585-5","article-title":"Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis","volume":"11","author":"Kvasnicka","year":"2018","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"10.1016\/j.blre.2025.101285_bb0220","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1200\/JCO.2010.34.5298","article-title":"Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study","volume":"29","author":"Barbui","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2025.101285_bb0225","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ajh.24288","article-title":"Myeloproliferative neoplasms: morphology and clinical practice","volume":"91","author":"Barbui","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2025.101285_bb0230","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/his.14846","article-title":"Myelofibrosis progression grading based on type I and type III collagen and fibrillin 1 expression boosted by whole slide image analysis","volume":"82","author":"Szekely","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.blre.2025.101285_bb0235","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0240","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.blre.2025.101285_bb0245","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1182\/blood-2018-10-844571","article-title":"Neutrophils as regulators of the hematopoietic niche","volume":"133","author":"Coss\u00edo","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0250","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.stem.2017.11.003","article-title":"Bone marrow myeloid cells regulate myeloid-biased hematopoietic stem cells via a histamine-dependent feedback loop","volume":"21","author":"Chen","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.blre.2025.101285_bb0255","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell\u2013suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0260","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.blre.2025.101285_bb0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13045-024-01562-5","article-title":"Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia","volume":"17","author":"Haage","year":"2024","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"10.1016\/j.blre.2025.101285_bb0270","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/bjh.12117","article-title":"Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population-based study of 327 patients","volume":"160","author":"Bonicelli","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2025.101285_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-019-0175-y","article-title":"Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model","volume":"9","author":"Vallapureddy","year":"2019","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.blre.2025.101285_bb0280","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/leu.2013.163","article-title":"Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study","volume":"27","author":"Tefferi","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2025.101285_bb0285","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/ajh.27079","article-title":"A globally applicable \u201ctriple a\u201d risk model for essential thrombocythemia based on age, absolute neutrophil count, and absolute lymphocyte count","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2025.101285_bb0290","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/09537104.2019.1693035","article-title":"Megakaryocyte emperipolesis: a new frontier in cell-in-cell interaction","volume":"31","author":"Cunin","year":"2020","journal-title":"Platelets"},{"key":"10.1016\/j.blre.2025.101285_bb0295","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exphem.2023.02.003","article-title":"Inhibition of CXCR1\/2 reduces the emperipolesis between neutrophils and megakaryocytes in the Gata1low model of myelofibrosis","volume":"121","author":"Arciprete","year":"2023","journal-title":"Exp Hematol"},{"key":"10.1016\/j.blre.2025.101285_bb0300","doi-asserted-by":"crossref","unstructured":"Cunin P, Bouslama R, Machlus KR, Mart\u00ednez-Bonet M, Lee PY, Wactor A, et al. Megakaryocyte emperipolesis mediates membrane transfer from intracytoplasmic neutrophils to platelets. eLife n.d.;8:e44031. doi:https:\/\/doi.org\/10.7554\/eLife.44031.","DOI":"10.7554\/eLife.44031"},{"key":"10.1016\/j.blre.2025.101285_bb0305","series-title":"A Phase II Study of Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium [MPN-RC 120]","author":"National Cancer Institute (NCI)","year":"2023"},{"key":"10.1016\/j.blre.2025.101285_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.683401","article-title":"Inflammatory pathophysiology as a contributor to myeloproliferative neoplasms","volume":"12","author":"Fisher","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2025.101285_bb0315","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3324\/haematol.2012.082560","article-title":"Increased reactive oxygen species production and p47phox phosphorylation in neutrophils from myeloproliferative disorders patients with JAK2 (V617F) mutation","volume":"98","author":"Hurtado-Nedelec","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2025.101285_bb0320","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1038\/sj.leu.2404338","article-title":"Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myeloid metaplasia","volume":"20","author":"Mesa","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2025.101285_bb0325","first-page":"1","article-title":"The role of neutrophil death in chronic inflammation and cancer","volume":"6","author":"Brostjan","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.blre.2025.101285_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029333","article-title":"Constitutive neutrophil apoptosis: regulation by cell concentration via S100 A8\/9 and the MEK \u2013 ERK pathway","volume":"7","author":"Atallah","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.blre.2025.101285_bb0335","article-title":"Cytokine consistency between bone marrow and peripheral blood in patients with Philadelphia-negative myeloproliferative neoplasms","volume":"8","author":"Chen","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.blre.2025.101285_bb0340","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1006\/cyto.2002.1994","article-title":"Abnormal production of interleukin (IL)-11 and IL-8 in polycythaemia vera","volume":"20","author":"Hermouet","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.blre.2025.101285_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.665037","article-title":"Bone marrow soluble mediator signatures of patients with Philadelphia chromosome-negative myeloproliferative neoplasms","volume":"11","author":"Cominal","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.blre.2025.101285_bb0350","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2010.07.427","article-title":"Evaluation of the bioactive and total transforming growth factor \u03b21 levels in primary myelofibrosis","volume":"53","author":"Campanelli","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.blre.2025.101285_bb0355","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2025.101285_bb0360","first-page":"2060","article-title":"CXCL8 and its cognate receptors CXCR1\/CXCR2 in primary myelofibrosis","volume":"109","author":"Vermeersch","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2025.101285_bb0365","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12952","article-title":"Cytokine production by human neutrophils: revisiting the \u201cdark side of the moon\u201d","volume":"48","author":"Tamassia","year":"2018","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.blre.2025.101285_bb0370","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1242\/dmm.012062","article-title":"Diverse functions of matrix metalloproteinases during fibrosis","volume":"7","author":"Giannandrea","year":"2014","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.blre.2025.101285_bb0375","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nri3499","article-title":"Metalloproteinases and their natural inhibitors in inflammation and immunity","volume":"13","author":"Khokha","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.blre.2025.101285_bb0380","doi-asserted-by":"crossref","first-page":"16518","DOI":"10.1074\/jbc.270.28.16518","article-title":"Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase","volume":"270","author":"Itoh","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2025.101285_bb0385","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1189\/jlb.69.6.851","article-title":"Gelatinase B functions as regulator and effector in leukocyte biology","volume":"69","author":"Opdenakker","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.blre.2025.101285_bb0390","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.blre.2025.101285_bb0395","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3324\/haematol.2017.168799","article-title":"Endotoxemia shifts neutrophils with TIMP-free gelatinase B\/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1","volume":"102","author":"Vandooren","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2025.101285_bb0400","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1182\/blood-2004-08-3238","article-title":"Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases","volume":"105","author":"Xu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0405","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1182\/blood.V124.21.5192.5192","article-title":"Higher MMP9 and FGF2 protein levels and elevated MMP9\/TIMP ratios were associated with JAK2V617F mutation regardless of allele burden in myelofibrosis","volume":"124","author":"Lima","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0410","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.it.2019.05.001","article-title":"The healing power of neutrophils","volume":"40","author":"Phillipson","year":"2019","journal-title":"Trends Immunol"},{"key":"10.1016\/j.blre.2025.101285_bb0415","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s12276-022-00742-y","article-title":"Inhibition of proinflammatory signaling impairs fibrosis of bone marrow mesenchymal stromal cells in myeloproliferative neoplasms","volume":"54","author":"Vukoti\u0107","year":"2022","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.blre.2025.101285_bb0420","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood.V96.8.2673","article-title":"Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact","volume":"96","author":"Van den Steen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0425","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jcp.21208","article-title":"Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you?","volume":"213","author":"Vincenti","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.blre.2025.101285_bb0430","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41375-023-01886-0","article-title":"Clonal architecture evolution in myeloproliferative neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape","volume":"37","author":"Maslah","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2025.101285_bb0435","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1038\/leu.2016.377","article-title":"Mass cytometry analysis reveals hyperactive NF kappa B signaling in myelofibrosis and secondary acute myeloid leukemia","volume":"31","author":"Fisher","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2025.101285_bb0440","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/blood.V93.10.3379.410k09_3379_3390","article-title":"Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34+ cells and their transmigration through reconstituted basement membrane","volume":"93","author":"Janowska-Wieczorek","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0445","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1196\/annals.1349.008","article-title":"Involvement of proteases in cytokine-induced hematopoietic stem cell mobilization","volume":"1044","author":"Velders","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.blre.2025.101285_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512133","article-title":"Novel matrix metalloproteinase-9 (MMP-9) inhibitors in Cancer treatment","volume":"24","author":"Rashid","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.blre.2025.101285_bb0455","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1165\/rcmb.2006-0012OC","article-title":"Neutrophil-derived elastase induces TGF-\u03b21 secretion in human airway smooth muscle via NF-\u03baB pathway","volume":"35","author":"Lee","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.blre.2025.101285_bb0460","article-title":"Noncanonical NF-\u03baB mediates the suppressive effect of neutrophil elastase on IL-8\/CXCL8 by inducing NKRF in human airway smooth muscle","volume":"7","author":"Ho","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.blre.2025.101285_bb0465","doi-asserted-by":"crossref","DOI":"10.1038\/srep10568","article-title":"Origin and evolution of lysyl oxidases","volume":"5","author":"Grau-Bov\u00e9","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.blre.2025.101285_bb0470","doi-asserted-by":"crossref","first-page":"24103","DOI":"10.1074\/jbc.M709897200","article-title":"Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells*","volume":"283","author":"Lucero","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2025.101285_bb0475","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1111\/jcmm.13753","article-title":"Increased Dkk-1 plasma levels may discriminate disease subtypes in myeloproliferative neoplasms","volume":"22","author":"Mambet","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.blre.2025.101285_bb0480","doi-asserted-by":"crossref","first-page":"24690","DOI":"10.1074\/jbc.M412979200","article-title":"Cellular fibronectin binds to Lysyl oxidase with high affinity and is critical for its proteolytic activation*","volume":"280","author":"Fogelgren","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2025.101285_bb0485","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/iub.2112","article-title":"Induction of LOX by TGF-\u03b21\/Smad\/AP-1 signaling aggravates rat myocardial fibrosis and heart failure","volume":"71","author":"Lu","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.blre.2025.101285_bb0490","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cyto.2011.03.024","article-title":"Induction of cardiac fibroblast lysyl oxidase by TGF-\u03b21 requires PI3K\/Akt, Smad3, and MAPK signaling","volume":"55","author":"Voloshenyuk","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.blre.2025.101285_bb0495","doi-asserted-by":"crossref","first-page":"27630","DOI":"10.1074\/jbc.M111.243113","article-title":"Control of megakaryocyte expansion and bone marrow fibrosis by Lysyl oxidase*","volume":"286","author":"Eliades","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2025.101285_bb0500","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/path.5449","article-title":"Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy","volume":"251","author":"Palmieri","year":"2020","journal-title":"J Pathol"},{"key":"10.1016\/j.blre.2025.101285_bb0505","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood-2023-181383","article-title":"PXS5505-MF-101: a phase 1\/2a study to evaluate safety, pharmacokinetics and pharmacodynamics of PXS-5505 in patients with primary, post-polycythemia vera or post-essential Thrombocythemia myelofibrosis","volume":"142","author":"Vachhani","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0510","author":"Syntara"},{"issue":"Supplement 1","key":"10.1016\/j.blre.2025.101285_bb0515","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1182\/blood-2024-204290","article-title":"Multicenter, Open-Label Phase 1\/2a Study of Pxs-5505 and Ruxolitinib in Patients with Primary, Post-Polycythemia Vera (PV) or Post-Essential Thrombocythemia (ET) Myelofibrosis","volume":"144","author":"Tan","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101285_bb0520","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41467-023-36620-y","article-title":"Citrullination modulates antigen processing and presentation by revealing cryptic epitopes in rheumatoid arthritis","volume":"14","author":"Curran","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.blre.2025.101285_bb0525","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.tcb.2022.01.014","article-title":"Insights into peptidylarginine deiminase expression and citrullination pathways","volume":"32","author":"Yu","year":"2022","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.blre.2025.101285_bb0530","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/JIR.S140188","article-title":"Mechanisms of NF-\u03baB p65 and strategies for therapeutic manipulation","volume":"11","author":"Giridharan","year":"2018","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.blre.2025.101285_bb0535","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aal3062","article-title":"Citrullination of NF-\u03baB p65 promotes its nuclear localization and TLR-induced expression of IL-1\u03b2 and TNF\u03b1","volume":"2","author":"Sun","year":"2017","journal-title":"Sci Immunol"},{"key":"10.1016\/j.blre.2025.101285_bb0540","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1182\/bloodadvances.2021006006","article-title":"Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST study","volume":"6","author":"Guglielmelli","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2025.101285_bb0545","article-title":"Novel method to quantify peptidylarginine deiminase activity shows distinct citrullination patterns in rheumatoid and juvenile idiopathic arthritis","volume":"14","author":"Yu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2025.101285_bb0550","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.matbio.2016.02.008","article-title":"Extracellular citrullination inhibits the function of matrix associated TGF-\u03b2","volume":"55","author":"Sipil\u00e4","year":"2016","journal-title":"Matrix Biol"},{"key":"10.1016\/j.blre.2025.101285_bb0555","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.matbio.2020.10.005","article-title":"Citrullination as a novel posttranslational modification of matrix metalloproteinases","volume":"95","author":"Boon","year":"2021","journal-title":"Matrix Biol"},{"key":"10.1016\/j.blre.2025.101285_bb0560","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3324\/haematol.2009.006973","article-title":"Citrullination of CXCL8 increases this chemokine\u2019s ability to mobilize neutrophils into the blood circulation","volume":"94","author":"Loos","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2025.101285_bb0565","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","article-title":"Interleukins (from IL-1 to IL-38), interferons, transforming growth factor \u03b2, and TNF-\u03b1: receptors, functions, and roles in diseases","volume":"138","author":"Akdis","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.blre.2025.101285_bb0570","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/onc.2010.479","article-title":"Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F","volume":"30","author":"Boissinot","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2025.101285_bb0575","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1096\/fj.11-193078","article-title":"Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms","volume":"26","author":"Hoermann","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.blre.2025.101285_bb0580","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s13402-018-0392-6","article-title":"TLR4 and RAGE conversely mediate pro-inflammatory S100A8\/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms","volume":"41","author":"Kova\u010di\u0107","year":"2018","journal-title":"Cell Oncol"},{"key":"10.1016\/j.blre.2025.101285_bb0585","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s12032-011-0144-1","article-title":"The relationship of the active and latent forms of TGF-\u03b21 with marrow fibrosis in essential thrombocythemia and primary myelofibrosis","volume":"29","author":"Ponce","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.blre.2025.101285_bb0590","author":"The Human Protein Atlas"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X2500030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X2500030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T03:03:02Z","timestamp":1749697382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X2500030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":118,"alternative-id":["S0268960X2500030X"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2025.101285","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophils in BCR::ABL1 negative MPN: Contributors or bystanders of fibrosis?","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2025.101285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101285"}}